Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQV3k0a2JLVkpObG5KNmttUjlPSGo1MHhicUNjZkQyQk1MTzNjb0VZdFJWbFFsZ25wY1JDNUlSaWQ2RnFXeDZEUC04VW9kRXhzQi1GT084aS12N2tBT3YxZENpQ0NUUzlMMWZFMklqOTlGRjlkbjhYSkhqV0dhVzNyT19GUGJWdDIxQ3RqY0RpU2F3SHpPZHFSMHFWcmVGLTdIcDVaX3R0UDlDYVlHc2xkUnNLbHVqZFhZU3c?oc=5" target="_blank">Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US drug agency approves breakthrough treatment for pancreatic cancer
Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.
August 26, 2026 at 10:02 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PMSuccess after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters
August 28, 2026 at 11:32 AMAstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AM